Fennec Pharmaceuticals Inc. (FENC)

NCM – Цена в реальном времени. Валюта: USD

11.02

+0.47 (4.45%)

При закрытии: Jun 26, 2026, 4:00 PM EDT

11.02

+0.00 (0.00%)

После закрытия: Jun 26, 2026, 4:31 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

Fennec Pharmaceuticals Inc. (FENC)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Fennec Pharmaceuticals Inc. (FENC)

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Fennec Announces Results of Annual Meeting

Adherex Technologies' PEDMARK Push Targets Larger AYA Market After Record Quarter

Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fennec Pharmaceuticals Inc. (FENC) Q1 2026 Earnings Call Transcript

Adherex Technologies Q1 Earnings Call Highlights

Видео

No Data

Пресс-релизы

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Fennec Announces Results of Annual Meeting

Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Search stocks

Fennec Pharmaceuticals Inc. (FENC)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Fennec Pharmaceuticals Inc. (FENC)

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Fennec Announces Results of Annual Meeting

Adherex Technologies' PEDMARK Push Targets Larger AYA Market After Record Quarter

Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fennec Pharmaceuticals Inc. (FENC) Q1 2026 Earnings Call Transcript

Adherex Technologies Q1 Earnings Call Highlights

Видео

No Data

Пресс-релизы

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Fennec Announces Results of Annual Meeting

Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)